Impact of the US election on medical device regulations
While Trump and Robert F Kennedy Jr have named the FDA as a target of particular interest for deregulation efforts, much of ...
In RFK Jr., drugmakers face an antagonist with regulatory power
Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...
Becker's Hospital Review11d
The future of FDA's medical device unit: 4 notes
Michelle Tarver, MD, PhD, a 15-year veteran of the agency, is stepping into a pivotal role as the new director of the FDA's device division, taking over for Jeffrey Shuren, MD. Dr. Shuren's tenure was ...
RFK Jr. vow to purge FDA sets up collision with Big Pharma
Kennedy has been most vocal about the FDA, an agency that oversees nearly $3 trillion in medicines, food and tobacco products ...
From AI to Musk’s brain chips, the FDA’s device unit faces rapid change
The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...
policymed.com18h
Updates from FDA’s Office of Prescription Drug Promotion: Standards for Direct-to-Consumer Advertising
In a recent presentation at the 25th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress, Catherine Gray, ...
Abolish the FDA (opinion)
Many seriously ill people die waiting for the FDA to approve drugs that regulators in other advanced countries have already ...
Cryptopolitan on MSN12d
FDA’s new device chief faces growing pressure as AI and tech transform healthcare
Dr. Michelle Tarver, a veteran of the Food and Drug Administration (FDA), has taken charge of the FDA’s device division at a ...
JD Supra3d
How the US Election May Affect the FDA Regulation of Life Sciences Products – Key Areas to Watch
The reelection of former President Donald Trump, coupled with Republicans gaining the Senate majority and poised to gain the House majority, ...
CCHR Int4h
CCHR Urges FDA Overhaul to End Psychiatric Drug and Device Harms
The Mental Health Watchdog calls for reforms to protect public safety, citing decades of antidepressant, electroshock, and psychedelic drug risks.
What awaits Harris or Trump at the FDA
The FDA faces policy challenges as technological advances roil health care and the agency fights for resources from Congress — no matter who wins the election.